Plan B Plaintiffs Expect to Face Court’s “Huge Deference” To FDA
This article was originally published in The Tan Sheet
A recently filed federal lawsuit challenging FDA's approval for OTC distribution of Plan B may present good cause for contesting the drug's approval, but will likely face an uphill battle, the plaintiffs acknowledge
You may also be interested in...
FDA's approval for OTC distribution of Plan B emergency contraceptive violated the Food, Drug, and Cosmetic and Administrative Procedure acts, as well as the due process clause of the Constitution, according to an April 12 lawsuit seeking to overturn the approval
FDA's decision to approve emergency contraceptive Plan B for over-the-counter sale to women age 18 and older cracks open the door on a pharmacy-only, behind-the-counter model for nonprescription drug sales
The Federal Trade Commission's senior staff attorney for advertising practices recommends firms stay away from using consumer testimonials to assert the benefits of their products